Cross-reactivity of Epstein-Barr Virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 4, 2001, Pages 747-756

  Lang, D ^a   Vornhagen, R ^a   Rothe, M ^a   Hinderer, W ^a   Sonneborn, H H ^a   Plachter, B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIGEN;

ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; GENE DELETION; HUMAN; IMMUNOGLOBULIN PRODUCTION; INFECTIOUS MONONUCLEOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CROSS REACTIONS; CYTOMEGALOVIRUS; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCINE; HERPESVIRUS 4, HUMAN; IMMUNOGLOBULIN M; KINETICS; MOLECULAR SEQUENCE DATA; POLYMERS; VIRAL PROTEINS;

EID: 0034968798     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.4.747-756.2001     Document Type: Article

References (53)

1. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection
2. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
3. The maturation of the immune response
4. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications
5. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection
6. Cytomegalovirus
7. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169
8. Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women
9. False-positive IgM antibody tests for cytomegalovirus in patients with acute Epstein-Barr virus infection
10. Combination of microneutralization and avidity assays: Improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy
11. Differentiation between acute primary and recurrent human cytomegalovirus infection in pregnancy, using a microneutralization assay
12. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease
13. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection
14. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification
15. Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology
16. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection
17. Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays
18. Viral antibodies in infectious mononucleosis
19. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain
20. Identification of immunoreactive viral proteins
21. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment
22. Activation of a varicella-zoster virus-specific IgA response during acute Epstein-Barr virus infection
23. Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay
24. Antibodies to human cytomegalovirus structural polypeptides during primary infection
25. Lack of correlation between virus detection and serologic tests for diagnosis of active cytomegalovirus infection in patients with AIDS
26. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM
27. New advances in the diagnosis of congenital cytomegalovirus infection
28. Prenatal indicators of congenital cytomegalovirus infection
29. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus
30. The DNA-binding protein pUL57 of human cytomegalovirus: Comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens
31. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer
32. Reactivity to p52 and CM2 recombinant proteins in primary human cytomegalovirus infection with a microparticle agglutination assay
33. Infections in solid-organ transplant recipients
34. IgM to human cytomegalovirus: Comparison of two enzyme immunoassays and IgM reactivity to viral polypeptides detected by immunoblotting
35. Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen
36. Identical IgM antibodies recognizing a glycine-alanine epitope are induced during acute infection with Epstein-Barr virus and cytomegalovirus
37. The p542 gene encodes an autoantigen that cross-reacts with EBNA-1 of the Epstein Bart virus and which may be a heterogeneous nuclear ribonucleoprotein
38. Epstein-Barr virus
39. Prokaryotic expression of the major capsid protein of human cytomegalovirus and antigenic cross-reactions with herpes simplex virus type 1
40. The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1)
41. A synthetic peptide for detecting antibodies to Epstein-Barr virus nuclear antigen in sera from patients with infectious mononucleosis
42. A synthetic peptide for detecting antibodies to Epstein-Barr virus nuclear antigen in sera from patients with infectious mononucleosis
43. Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants
44. Cytomegalovirus (CMV) antigenemia: Rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients
45. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein
46. Comparative immunoblot analysis with ten different, partially overlapping recombinant fusion proteins derived from five different cytomegalovirus proteins
47. Construction of recombinant autologous fusion proteins which enables IgG-specific serodiagnosis of past HCMV-infection
48. IgM-specific serodiagnosis of acute HCMV-infection using recombinant autologous fusion proteins
49. The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during active infection
50. Immunoglobulin A-specific serodiagnosis of acute human cytomegalovirus infection by using recombinant viral antigens
51. Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens
52. Serological diagnosis of cytomegalovirus infection: Comparison of 8 enzyme immunoassays for detection of HCMV-specific IgM antibody
53. Cytomegalovirus infections